Immunome Inc. 4

Horn Kinney, Chief Business Officer of Immunome Inc., exercised 1,092 stock options at $12.92 and sold 1,092 common shares at $25.00 on 2026-07-07 under a Rule 10b5-1 plan.

On July 7, 2026, Immunome Inc. Chief Business Officer Horn Kinney exercised employee stock options for 1,092 shares of common stock at an exercise price of $12.92 per share and immediately sold all 1,092 shares at $25.00 per share under a Rule 10b5-1 trading plan, realizing an implied spread of about $13,221 before taxes and fees. The transaction reflects a routine option exercise-and-sale rather than an open-market purchase, and following these trades the reporting person directly beneficially owned 128,908 shares of Immunome common stock, with an estimated post-transaction holding value of approximately $3.2 million based on the $25.00 sale price.

Filing Facts

CIK

1472012

Ticker

IMNM

Form

4

Source Type

fda

Accession

0001831215-26-000002

Alert Tier

5